Success Metrics

Clinical Success Rate

100.0%

Based on 2 completed trials

Completion Rate

100%(2/2)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Phase Distribution

Ph not_applicable

80%

Ph phase_1

20%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Phase 1Safety & dosage

1(20.0%)

N/ANon-phased studies

4(80.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(2)

Terminated(1)

Other(1)

Detailed Status

Completed2

Enrolling by invitation1

unknown1

Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 1

Trials by Phase

Phase 11 (20.0%)

N/A4 (80.0%)

Trials by Status

completed240%

enrolling_by_invitation120%

unknown120%

withdrawn120%

Recent Activity

0 active trials

Showing 5 of 5

completednot_applicable

Ozone Reaction Products and Skin Health

NCT06932419

enrolling_by_invitationnot_applicable

Pulmonary and Inflammatory Responses Following Exposure to a Low Concentration of Ozone or Clean Air at Rest

NCT06943989

unknownnot_applicable

Clinical Trials (5)

Showing 5 of 5 trials

NCT06932419Not Applicable

Ozone Reaction Products and Skin Health

Completed

NCT06943989Not Applicable

Pulmonary and Inflammatory Responses Following Exposure to a Low Concentration of Ozone or Clean Air at Rest

Enrolling By Invitation

NCT04669743Not Applicable

Innate Immunity in Ozone-induced Airway Inflammation in COPD

Unknown

NCT01492517Not Applicable

Epigenetic Effects of Diesel Exhaust and Ozone Exposure

Completed

NCT00468221Phase 1

The Effect of Low Level Ozone Exposure on Healthy Volunteers

Withdrawn

All 5 trials loaded

Drug Details

Intervention Type: OTHER
Total Trials: 5